Remember they are seeking FDA approval not only on Bio-t-gel eventually Libigel and other product. If they were to start making purchases or sales prior to releasing important information to public, that could negatively impact the relationship with the FDA. You want to above board and transparent on everything. I believe for that reason alone no insider trading has occurred. They haven't even announced the patent applications regarding Cardiovascular benefits.
I bet after tomorrows conference you will start to see insiders starting to purchase.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.